Company Earnings Update 4 minutesRegister for Free AccessCVS Health (NYSE: CVS) 1Q19 Results: Strong Aetna Performance Boosts Revenues, Prompts Guidance Raise Coresight Research May 3, 2019 Executive Summary CVS Health reported 1Q19 revenues of $61.6 billion, ahead of the consensus estimate and up 34.8% year over year. Adjusted EPS was $1.62, up 9.5% year over year and above the consensus estimate. CVS closed its acquisition of Aetna in Novesmber 2018, so this is the first full quarter of combined operations. For FY19, CVS raised adjusted EPS guidance to $6.75-6.90 from $6.68-6.88. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Innovator Profile: Lica World—Delivering Compelling AI-Created Video to Maximize ROASThe Impacts of US Tariffs: Assessing Companies’ International Sourcing Exposure by CountryKohl’s CEO Removal—Why It Happened and What It Means for US Department StoresWeekly UK Store Openings and Closures Tracker 2025, Week 23: Aldi and Topshop To Open Stores
